Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity was posted on August 12, 2008. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

RAPID HIV POINT-OF-CARE DIAGNOSTIC DEVICE FOR RESOURCE-LIMITED SETTINGS

Closed
NIH-NIAID-DAIDS-BAA-NIHAI2008027Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The National Institute of Allergies and Infectious Diseases is seeking a consortium of scientists to develop a rapid, point-of-care HIV diagnostic device specifically designed for use in resource-limited settings. The required device must be simple to use and function without supporting laboratory equipment such as centrifuges or pipettes. It must feature a clear visual output with internal controls and ensure safe containment of infectious materials with minimal sample manipulation. The ideal consortium will possess a diverse range of expertise spanning clinical HIV research, molecular technology, diagnostics, validation testing, GMP manufacturing, and project management. The agency intends to award one to two cost-reimbursement, completion-type contracts for a base period of five years, with options in years three and four for additional studies regarding viral load treatment decisions. This solicitation, identified as NIH-NIAID-DAIDS-BAA-NIHAI2008027, is managed by the NIAID and is open to all responsible sources. The project focuses on creating a feasible diagnostic tool capable of operating in POC clinics to improve HIV detection and management in underserved areas.

General Info

Agency

N/A

NAICS

541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Place of Performance

Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases Off, BETHESDA, MD, 20892, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Cecil ButlerContract Specialist

Full Description

Show more
This BAA solicitation seeks the development of a rapid HIV point-of-care diagnostic device for resource-limited settings (hereinafter referred to as rapid virus test.) The National Institute of Allergies and Infectious Diseases (NIAID) seeks to fund a consortium of scientists, possessing a breadth of complementary skills and expertise in clinical HIV research. The consortium should additionally possess expertise with associated molecular technology, diagnostics, validation testing, GMP manufacturing, and project management, with the goal of developing a simple to use, rapid, point-of-care (POC) HIV diagnostic device. The device should possess candidate vaccine constructs and developed vaccine-induced antibodies in the absence of true HIV-1 infections and HIV-infected infants. The diagnostic technology must demonstrate feasibility for use in resource-limited settings and in POC clinics without the use of supporting laboratory equipment. Examples of such equipment are centrifuges, vortexes and pipettes. In addition, if proposed testing requires processing of patient samples for downstream applications, the processing must be self- contained, and require limited sample manipulation, and provide safe containment of potentially infectious material. The optimal format is visual, without ambiguity, and includes a full process for negative and internal positive control. It is anticipated that 1 to 2 cost reimbursement, completion type contracts will be awarded on or about August 3, 2009 for a period of five years for the base period and options in years 3 and 4 for additional services; studies for a similar device to make limited treatment decisions based on viral load. NIAID-DAIDS-BAA-NIHAI2008027 will be available electronically on or about August 1, 2008, and may be accessed through FedBizOpps at http://www.fedbizopps.gov/. This advertisement does not commit the Government to award a contract. All responsible sources may submit a proposal which will be considered by the agency. No collect calls will be accepted. No facsimile transmissions will be accepted.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS